Partner Content Protected: Cell and gene therapy patents: What’s accelerating, what’s lagging behind There is no excerpt because this is a protected post. July 2, 2026 Share Copy Link Share on X Share on Linkedin Share on Facebook Cell and gene therapy patent filings fell 25% to May 2026, but grant ratios rose to 0.35. Credit: Shutterstock This content is password protected. To view it please enter your password below: Password: Sign up for our daily news round-up! Give your business an edge with our leading industry insights. Sign up